Delivery Order SPE2DR25D1109-SPE2DR26FFG6B
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Xeomin 200 Unit Vials, with a ceiling value of $23,553.20 and an ultimate completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Xeomin 100 Unit Vials, with a ceiling value of $17,664.60 and a firm fixed price contract structure. This is a non-set-aside delivery order with an ultimate completion date of December 2, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's substantial role as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Xeomin 200 Unit Vials with a ceiling value of $2,793.70 and an ultimate completion date of October 2, 2025. This firm fixed price, competitively awarded delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is listed as Conshohocken, Pennsylvania, which...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,888.30 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 unit vials. This competitively awarded, firm fixed-price delivery order, issued on November 14, 2025, will be fulfilled by the vendor's corporate office located in Conshohocken, Pennsylvania, with an ultimate completion date of December 8, 2025. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,197.88 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 Unit Vials. This firm fixed-price delivery order, issued on November 13, 2025, is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis and represents a purchase of a specialized pharmaceutical product used...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on August 23, 2025, for the supply of Xeomin 100 Unit vials. The contract ceiling value is $11,174.80, with an ultimate completion date of September 12, 2025. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside contract awarded through competitive procurement, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,676.22 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a pharmaceutical product used for neurological and aesthetic applications. This firm fixed price, non-set-aside contract was awarded on October 27, 2025, with an ultimate completion date of November 18, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a $93,868.32 firm fixed-price delivery order for 200-unit vials of Xeomin on October 17, 2025, with an ultimate completion date of November 7, 2025. This non-competitive delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $9,609.60 to AmerisourceBergen Drug Corp for the supply of Xeomin 50 Unit Vials. This firm fixed-price, non-set-aside contract was awarded on November 4, 2025, with an ultimate completion date of November 26, 2025. The place of performance is located in Conshohocken, Pennsylvania, the vendor's corporate headquarters. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,117.48 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Xeomin 200 Unit Vials. This firm fixed-price delivery order, with an ultimate completion date of October 16, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive, non-set-aside procurement action and is issued under AmerisourceBergen's existing Indefinite Delivery...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFG6BDelivery Order
The Defense Logistics Agency awarded a $23,553.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Xeomin 200 Unit Vials. The contract, issued on November 17, 2025, has an ultimate completion date of December 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal procurement requirements through open competition. This award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's extensive federal contract portfolio demonstrates its role as a critical vendor for military and veteran healthcare systems, delivering specialty medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.6k | 11/17/25 |